1. Announcement Details

On February 24, 2025, the Department of Health received Decision No. 92/QĐ-QLD from the Drug Administration of Vietnam (DAV) under the Ministry of Health regarding the revocation of marketing authorization for certain drugs in Vietnam. This measure is essential to ensure public safety and maintain quality control over pharmaceuticals in the market.

2. List of Revoked Drugs

According to the decision, five drugs have been withdrawn due to failure to meet quality, safety, or efficacy standards. Pharmacies and pharmaceutical businesses should immediately review their inventory and take appropriate action in compliance with regulations.

3. What Should Pharmacies Do If They Have the Recalled Drugs?

🔹 Check the list of revoked drugs to determine if they have any in stock.
🔹 Immediately stop purchasing or selling the affected products.
🔹 Report and coordinate with regulatory authorities to ensure proper recall procedures and compliance with Good Pharmacy Practices (GPP) regulations.

4. Why Is It Important to Pay Attention to Drug Recalls?

The revocation of drug marketing authorization is typically due to concerns about quality, safety, or effectiveness. Failure to address these recalls promptly can lead to serious risks, including:

✅ Potential harm to consumer health.
✅ Loss of reputation and violations of Ministry of Health regulations.
✅ Financial losses from stocking unauthorized drugs.

5. How Can SPHACY Support Pharmacies?

Do you need a system to manage drug inventories and stay updated on recall decisions in real time? SPHACY is the solution for you!

✔️ Instant updates on recalled drugs, preventing pharmacies from stocking unauthorized products.
✔️ Smart inventory management, tracking expiration dates and automating stock control.
✔️ Full compliance with GPP regulations, ensuring smooth and secure pharmacy operations.

📌 See the official decision and the list of revoked drugs in the attached appendix: